Company Quick10K Filing
Quick10K
Kiniksa Pharmaceuticals
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
S-1 2019-01-28 Public Filing
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
8-K 2019-11-12 Officers
8-K 2019-10-28 Earnings, Exhibits
8-K 2019-08-12 Earnings, Regulation FD, Exhibits
8-K 2019-05-29 Shareholder Vote
8-K 2019-05-02 Earnings, Exhibits
8-K 2019-03-04 Earnings, Officers, Exhibits
8-K 2019-01-28
8-K 2019-01-28 Sale of Shares
8-K 2018-11-12 Enter Agreement, Exhibits
8-K 2018-11-01 Earnings, Exhibits
8-K 2018-09-17 Regulation FD, Exhibits
8-K 2018-09-13 Regulation FD, Exhibits
8-K 2018-08-06 Earnings, Exhibits
8-K 2018-05-29 Amend Bylaw, Exhibits

Kiniksa Pharmaceuticals Financials

-

KNSA Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comparables ($'000 Annual) Ticker Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Advaxis ADXS 5,775 56,133 6,864 22,012 0 1,812 3,429 -35,980
Tonix Pharmaceuticals Holding TNXP 8,683 15,008 2,186 0 0 -23,639 -23,595 -3,567
Delmar Pharmaceuticals DMPI 10 4,037 2,070 0 0 8,048 8,048 -3,709
Diffusion Pharmaceuticals DFFN 1,924 18,929 2,752 0 0 -17,534 -17,962 -6,448
Phibro Animal Health PAHC 0 726,671 510,656 624,112 264,624 54,713 109,193 173,717
OHR Pharmaceutical OHRP 10,129 8,693 752 0 0 -9,529 -8,750 8,704
Therapix Biosciences TRPX 0 4,560 -0 0 0 0 0 -1,518
AstraZeneca AZN -0 60,651,000 46,607,000 0 0 0 0 -893,000
Kiniksa Pharmaceuticals KNSA -0 308,137 32,940 0 0 -169,998 -170,154 -287,447
Bioblast Pharma ORPN 39,270 11,034 1,328 0 0 -3,073 -3,073 29,534
Zomedica Pharmaceuticals ZOM -0 9,479 1,797 0 0 -24,413 -24,124 -5,822
Trillium Therapeutics TRIL -0 55,459 13,858 0 0 0 0 -0
Nabriva Therapeutics NBRV 678,758 83,645 40,240 3,486 0 -125,573 -123,455 629,164
Grifols GRFS -0 12,477,046 7,780,442 0 0 0 0 -592,178
VTV Therapeutics VTVT -0 9,072 21,914 10,646 0 -6,924 -4,119 5,935
Immtech Pharmaceuticals IMMP
Novo Nordisk NVO
Affimed AFMD -0 116,174 -0 0 0 0 0 -0
Zealand Pharma ZEAL
Intec Pharma NTEC -0 46,860 11,751 0 0 -20,665 -20,593 -20,796

Balance Sheet ($'000)2018-06-302018-09-302018-12-312019-03-312019-06-30
Cash359,190337,863307,304326,533287,447
Accounts Receivable
Inventory
PP&E4032,4266,6756,9807,657
Assets365,129347,101321,965346,159308,137
Accounts Payable5614,66810,9186,8909,338
Long-Term Debt
Liabilities23,33028,18842,69839,64032,940
Stockholders' Equity341,799318,913279,267306,519275,197
Income Statement ($'000)2018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue
Cost of Revenue
Gross Profit
R&D17,20020,64436,12259,25330,848
SG&A
Tax-20219738-17-374
Net Income-20,259-24,406-42,580-65,821-37,191
Cash Flow ($'000)2018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-20,485-27,638-63,256-41,676
Cash Investing-194,87129,660-9,27841,363
Cash Financing-76229183,187494